Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.
Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.
Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.
The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.
Related Stories
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
IHH Healthcare's Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure across the Pantai Hospitals Group.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
IHH Healthcare Singapore Unveils Parkway Rehab and Healing Garden at Mount Elizabeth Hospital
The launch of Parkway Rehab and its Healing Garden marks a new chapter in patient rehabilitation, offering a supportive environment to help patients regain independence.
